Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Summit Therapeutics (SMMT) Goodwill & Intangibles (2018 - 2025)

Summit Therapeutics' Goodwill & Intangibles history spans 8 years, with the latest figure at $2.0 million for Q3 2025.

  • For Q3 2025, Goodwill & Intangibles changed 0.4% year-over-year to $2.0 million; the TTM value through Sep 2025 reached $2.0 million, changed 0.4%, while the annual FY2024 figure was $1.9 million, 1.53% down from the prior year.
  • Goodwill & Intangibles reached $2.0 million in Q3 2025 per SMMT's latest filing, down from $2.0 million in the prior quarter.
  • In the past five years, Goodwill & Intangibles ranged from a high of $13.4 million in Q1 2021 to a low of $1.8 million in Q4 2022.
  • Average Goodwill & Intangibles over 5 years is $5.6 million, with a median of $2.0 million recorded in 2024.
  • Peak YoY movement for Goodwill & Intangibles: skyrocketed 3451.5% in 2021, then crashed 85.51% in 2022.
  • A 5-year view of Goodwill & Intangibles shows it stood at $12.4 million in 2021, then tumbled by 85.51% to $1.8 million in 2022, then increased by 5.28% to $1.9 million in 2023, then fell by 1.53% to $1.9 million in 2024, then increased by 7.24% to $2.0 million in 2025.
  • Per Business Quant, the three most recent readings for SMMT's Goodwill & Intangibles are $2.0 million (Q3 2025), $2.0 million (Q2 2025), and $1.9 million (Q1 2025).